pI: 7.5055 |
Length (AA): 182 |
MW (Da): 21434 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 7 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
1 | 168 | 2fck (A) | 1 | 176 | 13.00 | 0 | 1 | 1.04 | -0.88 |
15 | 172 | 1vhs (A) | 0 | 164 | 17.00 | 0 | 0.99 | 1.12 | -0.94 |
16 | 146 | 1z4e (A) | 5 | 143 | 20.00 | 0 | 0.86 | 1.01 | -1.34 |
14 | 177 | 2ob0 (C) | 4 | 161 | 28.00 | 0 | 1 | 1.3092 | -0.71 |
15 | 170 | 4r3l (A) | 11 | 167 | 23.00 | 0 | 1 | 1.17624 | -0.72 |
42 | 168 | 1ghe (A) | 49 | 171 | 17.00 | 0 | 0.75 | 0.869502 | -0.11 |
78 | 158 | 4m85 (A) | 104 | 180 | 35.00 | 0.1 | 0.81 | 0.666655 | 0.37 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | amastigotes. | Fernandes MC |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | metacyclic. | Fernandes MC |
Fernandes MC | Dual Transcriptome Profiling of Leishmania-Infected Human Macrophages Reveals Distinct Reprogramming Signatures. |
Ortholog group members (OG5_128600)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G11340 | GCN5-related N-acetyltransferase (GNAT) family protein |
Brugia malayi | Bm1_06410 | acetyltransferase, GNAT family protein |
Candida albicans | CaO19.490 | potential N-acetyl tranferase (GNAT family) similar to S. cerevisiae NAT5 (YOR253W) peptide alpha-N-acetyltransferase |
Candida albicans | CaO19.8120 | potential N-acetyl tranferase (GNAT family) similar to S. cerevisiae NAT5 (YOR253W) peptide alpha-N-acetyltransferase |
Caenorhabditis elegans | CELE_F40F4.7 | Protein F40F4.7 |
Dictyostelium discoideum | DDB_G0295721 | GCN5-related N-acetyltransferase |
Drosophila melanogaster | Dmel_CG12352 | separation anxiety |
Echinococcus granulosus | EgrG_000215400 | n alpha acetyltransferase 50 NatE catalytic |
Entamoeba histolytica | EHI_139360 | acetyltransferase, GNAT family |
Echinococcus multilocularis | EmuJ_000215400 | n alpha acetyltransferase 50, NatE catalytic |
Homo sapiens | ENSG00000121579 | N(alpha)-acetyltransferase 50, NatE catalytic subunit |
Leishmania braziliensis | LbrM.03.0140 | acetyltransferase, putative |
Leishmania donovani | LdBPK_030120.1 | acetyltransferase, putative |
Leishmania infantum | LinJ.03.0120 | acetyltransferase, putative |
Leishmania major | LmjF.03.0130 | acetyltransferase, putative |
Leishmania mexicana | LmxM.03.0130 | acetyltransferase, putative |
Loa Loa (eye worm) | LOAG_11415 | acetyltransferase |
Mus musculus | ENSMUSG00000022698 | N(alpha)-acetyltransferase 50, NatE catalytic subunit |
Neospora caninum | NCLIV_026890 | acetyltransferase domain-containing protein, putative |
Oryza sativa | 4327733 | Os01g0610400 |
Saccharomyces cerevisiae | YOR253W | Nat5p |
Schistosoma japonicum | Sjp_0120450 | ko:K00680 Mak3 homolog [EC:2.3.1.-], putative |
Schistosoma mansoni | Smp_006780 | hypothetical protein |
Schmidtea mediterranea | mk4.002874.01 | N-alpha-acetyltransferase 50 |
Schmidtea mediterranea | mk4.001198.01 | N-alpha-acetyltransferase 50 |
Schmidtea mediterranea | mk4.004031.01 | N-alpha-acetyltransferase 50 |
Trypanosoma brucei gambiense | Tbg972.10.3980 | N-acetyltransferase, putative |
Trypanosoma brucei | Tb927.10.3150 | N-acetyltransferase, putative |
Trypanosoma congolense | TcIL3000_10_2610 | N-acetyltransferase, putative |
Trypanosoma cruzi | TcCLB.510943.100 | acetyltransferase, putative |
Trypanosoma cruzi | TcCLB.504867.40 | acetyltransferase, putative |
Toxoplasma gondii | TGME49_260010 | acetyltransferase, GNAT family protein |
Trichomonas vaginalis | TVAG_363670 | N-terminal acetyltransferase, putative |
Trichomonas vaginalis | TVAG_116150 | N-acetyltransferase separation anxiety, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.3150 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.3150 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.3150 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.10.3150 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
TGME49_260010 | Toxoplasma gondii | Probably essential | sidik |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.